0 items / CHF0.00

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

<img src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/02/legacy-pharmaceuticals-logo.png" alt="Legacy Pharmaceuticals" style="max-width: 180px;" />

0 items / CHF0.00

margenza

Click to enlarge

Previous product

<img width="600" height="600" src="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-10_at_6.16.03_pm-600x600.png" class="attachment-woocommerce_thumbnail size-woocommerce_thumbnail" alt="" srcset="https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-10_at_6.16.03_pm-600x600.png 600w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-10_at_6.16.03_pm-300x300.png 300w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-10_at_6.16.03_pm-150x150.png 150w, https://legacypharmaceuticals.ch/wp-content/uploads/2022/03/screenshot_2021-05-10_at_6.16.03_pm.png 700w" sizes="(max-width: 600px) 100vw, 600px" />

Orgovyx (relugolix) CHF3,563.17

Back to products

Next product

Danyelza (naxitamab-gqgk) CHF35,282.47

Margenza (margetuximab-cmkb)

CHF2,720.25

Margenza (margetuximab-cmkb) is a medication used in combination with chemotherapy, to treat adults with metastatic HER2-positive breast cancer after at least two previous rounds of therapy.

Add to wishlist

Category: Oncology

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Margenza (margetuximab-cmkb)”

Start typing to see products you are looking for.

No account yet?

Create an Account